Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A13467 | 29957886 | J Diabetes Investig | Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: A randomized trial. | 2018 | Details |
| A13469 | 29956688 | Saudi J Gastroenterol | Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030. | 2018 | Details |
| A13471 | 29956212 | Adv Exp Med Biol | Animal Models of Non-alcoholic Fatty Liver Diseases and Its Associated Liver Cancer. | 2018 | Details |
| A13476 | 29956207 | Adv Exp Med Biol | Hepatocellular Carcinoma in Obesity: Finding a Needle in the Haystack? | 2018 | Details |
| A13480 | 29956203 | Adv Exp Med Biol | Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC. | 2018 | Details |
| A13481 | 29956202 | Adv Exp Med Biol | Introduction. | 2018 | Details |
| A13488 | 29953011 | Medicine (Baltimore) | Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China. | 2018 | Details |
| A13492 | 29951362 | J Clin Transl Hepatol | Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies. | 2018 | Details |
| A13500 | 29947103 | Eur J Clin Invest | Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver disease. | 2018 | Details |
| A13506 | 29943733 | J Breath Res | The characterisation of hepatic mitochondrial function in patients with non-alcoholic fatty liver disease (NAFLD) using the 13C-ketoisocaproate breath test. | 2018 | Details |
| A13509 | 29942096 | Nat Med | Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. | 2018 | Details |
| A13514 | 29936743 | Zhonghua Liu Xing Bing Xue Za Zhi | [Association between fatty liver and type 2 diabetes in the baseline population of Jinchang Cohort]. | 2018 | Details |
| A13517 | 29935547 | J Pharm Pharm Sci | Effects of Canagliflozin on Fatty Liver Indexes in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials. | 2018 | Details |
| A13523 | 29931613 | Curr Diab Rep | The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes. | 2018 | Details |
| A13530 | 29929399 | Ann Med | The association of non-alcoholic fatty liver disease and atrial fibrillation: a review. | 2018 | Details |
| A13533 | 29927747 | J Complement Integr Med | Terminalia Sericea aqueous leaf extract protects growing wistar rats against fructose-induced fatty liver disease. | 2018 | Details |
| A13550 | 29915740 | J Family Med Prim Care | A study on the altered glycemic and lipid parameters and prevalence of insulin resistance in nonalcoholic fatty liver disease. | 2022 | Details |
| A13567 | 29904722 | Clin Exp Hepatol | Underrated enemy - from nonalcoholic fatty liver disease to cancers of the gastrointestinal tract. | 2018 | Details |
| A13582 | 29895557 | Diabetes Care | Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial). | 2018 | Details |
| A13584 | 29895006 | Front Horm Res | The Metabolic Syndrome in Central Hypogonadotrophic Hypogonadism. | 2018 | Details |
| A13586 | 29893699 | Ann Hepatol | Impact of Diabetes Mellitus and Insulin on Nonalcoholic Fatty Liver Disease in the Morbidly Obese. | 2019 | Details |
| A13589 | 29892281 | Front Immunol | Distinct Housing Conditions Reveal a Major Impact of Adaptive Immunity on the Course of Obesity-Induced Type 2 Diabetes. | 2018 | Details |
| A13599 | 29886156 | J Hepatol | Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. | 2018 | Details |
| A13622 | 29869810 | Diabet Med | Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme. | 2018 | Details |
| A13633 | 29861312 | J Diabetes Complications | Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control. | 2018 | Details |
| A13637 | 29860108 | Atherosclerosis | Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver. | 2018 | Details |
| A13640 | 29859544 | Br J Nutr | Do inositol supplements enhance phosphatidylinositol supply and thus support endoplasmic reticulum function? | 2018 | Details |
| A13650 | 29856820 | PLoS One | Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study. | 2018 | Details |
| A13658 | 29852394 | Biomed Pharmacother | Naringin attenuates liver damage in streptozotocin-induced diabetic rats. | 2018 | Details |
| A13663 | 29849912 | Oxid Med Cell Longev | The Essential Element Manganese, Oxidative Stress, and Metabolic Diseases: Links and Interactions. | 2018 | Details |
| A13668 | 29847555 | PLoS One | Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH. | 2018 | Details |
| A13673 | 29845362 | Wien Klin Wochenschr | Increased intermediate monocyte fraction in peripheral blood is associated with nonalcoholic fatty liver disease. | 2018 | Details |
| A13683 | 29808958 | Clin Physiol Funct Imaging | Cardiometabolic effects of antidiabetic drugs in non-alcoholic fatty liver disease. | 2018 | Details |
| A13688 | 29804898 | Trends Endocrinol Metab | Sleeve Gastrectomy: Metabolic Surgical Procedure of Choice? | 2018 | Details |
| A13698 | 29802679 | J Diabetes Investig | Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis. | 2018 | Details |
| A13701 | 29802129 | Diabetes | Production of Elastin-Derived Peptides Contributes to the Development of Nonalcoholic Steatohepatitis. | 2018 | Details |
| A13720 | 29792708 | Mol Pharm | Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver. | 2018 | Details |
| A13726 | 29788220 | Endocrinology | Obstructive Sleep Apnea Syndrome and Metabolic Diseases. | 2018 | Details |
| A13728 | 29787859 | Contemp Clin Trials | Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease. | 2018 | Details |
| A13729 | 29787418 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis. | 2018 | Details |
| A13742 | 29779697 | Dig Liver Dis | Usefulness of controlled attenuation parameter for detecting increased arterial stiffness in general population. | 2018 | Details |
| A13745 | 29779083 | Dig Dis Sci | Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration. | 2018 | Details |
| A13748 | 29778128 | J Natl Med Assoc | The Relationship Between Glycaemic Control and Non-Alcoholic Fatty Liver Disease in Nigerian Type 2 Diabetic Patients. | 2017 | Details |
| A13756 | 29772784 | Nutrients | Capsaicin in Metabolic Syndrome. | 2018 | Details |
| A13762 | 29769484 | Mymensingh Med J | Prevalence of Non-Alcoholic Fatty Liver Disease and Its Biochemical Predictors in Patients with Type-2 Diabetes Mellitus. | 2018 | Details |
| A13764 | 29768686 | J Viral Hepat | Prevalence and predictive factors of moderate/severe liver steatosis in chronic hepatitis C (CHC) infected patients evaluated with controlled attenuation parameter (CAP). | 2018 | Details |
| A13773 | 29764908 | Eur J Endocrinol | MANAGEMENT OF ENDOCRINE DISEASE: Which metabolic procedure? Comparing outcomes in sleeve gastrectomy and Roux-en Y gastric bypass. | 2018 | Details |
| A13798 | 29750881 | Physiol Res | Pathophysiological characteristics of non-alcoholic steatohepatitis-like changes in cholesterol-loaded type 2 diabetic rats. | 2018 | Details |
| A13799 | 29749571 | J Gastroenterol | Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients. | 2018 | Details |
| A13826 | 29739703 | Trends Endocrinol Metab | Hippo Signaling: Key Emerging Pathway in Cellular and Whole-Body Metabolism. | 2018 | Details |
| A13837 | 29734463 | Hepatology | Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People. | 2018 | Details |
| A13846 | 29729151 | Wiad Lek | Subclinical hypothyroidism in patients with non-alcoholic fatty liver disease at the background of carbohydrate metabolism disorders. | 2019 | Details |
| A13849 | 29728363 | Diabetes | Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes. | 2018 | Details |
| A13857 | 29723898 | Horm Metab Res | The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13868 | 29719529 | Front Endocrinol (Lausanne) | ANGPTL8: An Important Regulator in Metabolic Disorders. | 2018 | Details |
| A13870 | 29718334 | J Clin Endocrinol Metab | Low-Dose Levothyroxine Reduces Intrahepatic Lipid Content in Patients With Type 2 Diabetes Mellitus and NAFLD. | 2018 | Details |
| A13918 | 29693586 | Nutrients | Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats. | 2018 | Details |
| A13922 | 29690638 | Nutrients | Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity. | 2018 | Details |
| A13924 | 29688336 | Inflamm Bowel Dis | Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors. | 2018 | Details |
| A13937 | 29680836 | Dig Dis | Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes. | 2018 | Details |
| A14006 | 29641680 | Rev Assoc Med Bras (1992) | Nonalcoholic steatohepatitis in posttransplantation liver: Review article. | 2018 | Details |
| A14010 | 29635305 | Adv Nutr | Modeling the Western Diet for Preclinical Investigations. | 2018 | Details |
| A14012 | 29634665 | Eur J Gastroenterol Hepatol | Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring. | 2018 | Details |
| A14017 | 29632425 | World J Gastroenterol | Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis. | 2018 | Details |
| A14019 | 29631765 | Diabetes Metab | Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes. | 2018 | Details |
| A14035 | 29622904 | Ethiop J Health Sci | Non-Alcoholic Fatty Liver Disease and Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia. | 2018 | Details |
| A14048 | 29613841 | Radiology | Increased Pancreatic Echogenicity with US: Relationship to Glycemic Progression and Incident Diabetes. | 2018 | Details |
| A14051 | 29609450 | Ann Pediatr Endocrinol Metab | Hepatopulmonary syndrome caused by hypothalamic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma: a case report. | 2018 | Details |
| A14052 | 29609136 | Cytokine | Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses. | 2018 | Details |
| A14053 | 29608898 | Eur J Pharmacol | Canagliflozin protects against non-alcoholic steatohepatitis in type-2 diabetic rats through zinc alpha-2 glycoprotein up-regulation. | 2018 | Details |
| A14056 | 29608255 | Liver Int | Twenty-five-year trajectories of insulin resistance and pancreatic β-cell response and diabetes risk in nonalcoholic fatty liver disease. | 2018 | Details |
| A14078 | 29600696 | Minerva Gastroenterol Dietol | Helicobacter pylori in metabolic related diseases. | 2018 | Details |
| A14080 | 29600430 | Hepatol Int | Targeting incretin hormones and the ASK-1 pathway as therapeutic options in the treatment of non-alcoholic steatohepatitis. | 2018 | Details |
| A14094 | 31089541 | J Obes Metab Syndr | Nonalcoholic Fatty Liver Disease and Abdominal Fat Accumulation According to Vitamin D Status in Patients with Type 2 Diabetes. | 2018 | Details |
| A14095 | 29590379 | J Clin Endocrinol Metab | Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes. | 2018 | Details |
| A14096 | 29590099 | PLoS Med | Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database. | 2018 | Details |
| A14109 | 29577863 | Curr Clin Pharmacol | Hepatic Elimination of Drugs in Gestational Diabetes. | 2018 | Details |
| A14111 | 29577560 | Liver Int | Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population. | 2018 | Details |
| A14114 | 29575516 | Liver Int | Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease. | 2018 | Details |
| A14118 | 29574933 | Clin Exp Pharmacol Physiol | The association of serum FGF23 and non-alcoholic fatty liver disease is independent of vitamin D in type 2 diabetes patients. | 2018 | Details |
| A14139 | 29567280 | Bull Cancer | [Hepatocellular carcinoma: Increase in incidence or future plague?] | 2018 | Details |
| A14160 | 29558390 | Int J Mol Sci | PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders. | 2018 | Details |
| A14162 | 29557414 | J Gastrointestin Liver Dis | A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial. | 2018 | Details |
| A14201 | 29527789 | Diabetes Obes Metab | Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2018 | Details |
| A14203 | 29527255 | World J Hepatol | Glycogenic hepatopathy: A narrative review. | 2018 | Details |
| A14218 | 29519663 | Surg Obes Relat Dis | Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease? | 2017 | Details |
| A14234 | 29512720 | Mol Med Rep | Alogliptin alleviates hepatic steatosis in a mouse model of nonalcoholic fatty liver disease by promoting CPT1a expression via Thr172 phosphorylation of AMPKα in the liver. | 2018 | Details |
| A14240 | 29509436 | Am J Physiol Endocrinol Metab | Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. | 2018 | Details |
| A14247 | 29507217 | Proc Natl Acad Sci U S A | High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism. | 2018 | Details |
| A14249 | 29506157 | J Clin Endocrinol Metab | Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose. | 2018 | Details |
| A14253 | 29504312 | J Zhejiang Univ Sci B | Role of exosome-associated microRNA in diagnostic and therapeutic applications to metabolic disorders. | 2018 | Details |
| A14254 | 29503789 | Curr Hepatol Rep | Managing the Burden of Non-NASH NAFLD. | 2017 | Details |
| A14262 | 29497497 | F1000Res | The role of NAFLD in cardiometabolic disease: an update. | 2018 | Details |
| A14266 | 29493856 | Liver Int | Analysis of genotyping for predicting liver injury marker, procollagen III in persons at risk of non-alcoholic fatty liver disease. | 2018 | Details |
| A14274 | 29488485 | Ter Arkh | [Nonalcoholic fatty liver disease without obesity: the problem to be solved]. | 2019 | Details |
| A14285 | 29483369 | Biosci Rep | Maternal obesity increases the risk of metabolic disease and impacts renal health in offspring. | 2018 | Details |
| A14296 | 29477355 | Endocrinol Diabetes Nutr (Engl Ed) | Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes. | 2018 | Details |
| A14306 | 29471595 | Diabetes Metab Res Rev | Procollagen-III peptide identifies adipose tissue-associated inflammation in type 2 diabetes with or without nonalcoholic liver disease. | 2018 | Details |
| A14311 | 29470354 | Transplantation | Poor Survival After Retransplantation in NASH Cirrhosis. | 2019 | Details |
| A14323 | 29466466 | PLoS One | Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach. | 2018 | Details |